medigraphic.com
ISSN 1561-302X (Print)

2013, Number 1

<< Back Next >>

Rev cubana med 2013; 52 (1)

Colonoscopy like gold standard test for colorectal cancer screening

Montes de Oca ME, Noa PG, García JE, Seijas CO, Pérez TF, Brizuela QR

Language: Spanish
References: 58
Page: 60-70
PDF size: 59.40 Kb.


ABSTRACT

Colorectal cancer presents a high incidence and mortality. In spite of this, current developing screening programs are not enough to modify its behavior. Colonoscopy is the gold test for this neoplasia investigation and diagnostic and its premalignant lesions, since it gives the possibility of the colon total exploration: However, its high cost and readiness hold detractors concerning its use as a primary method of screening. this issue was reviewed on the usefulness of colonoscopy as a screening tool to reduce morbidity and mortality from colorectal cancer.


REFERENCES

  1. WGO/IDCA Internacional para Cáncer Digestivo: Tamizaje del cáncer colorrectal. [citado 28 Mar. 2012] Disponible en: http://www.worldgastroenterology.org/colorrectal-cancer-screening.html

  2. Riemann JF. Colorrectal cancer screening in Europe: compliance and the choice of test. Endoscopy. 2010;42:576-7.

  3. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765-81.

  4. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010 CA Cancer J Clin. 2010;60(5):277-300.

  5. Day L W, Walter L C, Velayos F. Colorrectal Cancer Screening and Surveillance in the Elderly Patient.Am J Gastroenterol. 2011;106:1197206; doi: 10.1038/ajg.2011.128; published online 26 Apr. 2011.

  6. República de Cuba. Oficina Nacional de Estadísticas e Información. Anuario Estadístico de Cuba 2010, edición 2011. La Habana; 2011.

  7. Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam. 1968;65(4):281-93.

  8. Morales Cuenca G, Aguayo Albasini JL. Cribaje del cáncer colorrectal en la población de bajo riesgo (sin factores de riesgo conocidos). Arch Cir Gen Dig. 28 Jul. 2003. [citado 16 Mar. 2012]Disponible en: http://www.cirugest.com/revista/2003-07-28.htm

  9. Lieberman D. Colorrectal cancer screening in primary care. Gastroenterology. 2007;132:2591-4.

  10. Smith RA, Cokkinides V, Brawley OW. Cancer Screening in the United States, 2012. A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening. Ca Cancer J Clin. 2012;62:129-42.

  11. Wang A, Lieberman D. Screening Guidelines for Colorrectal Cancer: What Should We Advocate to Our Patients? Curr Colorrectal Cancer Rep. 2010;6:8 doi 15.D 10.1007/s11888-009-0036-3.

  12. Lieberman D. Progress and Challenges in Colorrectal Cancer Screening and Surveillance. Gastroenterology. 2010;138:2115-26.

  13. U.S. Preventive Services Task Force. Screening for colorrectal cancer: recommendation and rationale. Ann. Intern. Med. 2002;137:129-31.

  14. Calonge Nt al. Screening for colorrectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008,149:627-37.

  15. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorrectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorrectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008,58:130-60.

  16. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorrectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009,104:739-50.

  17. Hoff G, Dominitz JA. Contrasting US and European approaches to colorrectal cancer screening: which is best? Gut. 2010;59:407-4.

  18. Bretthauer M. Colorrectal cancer screening. J Intern Med. 2011;270:87-98.

  19. Colorrectal cancer screening in average-risk population: immunochemical 11 fecal occult blood testing versus colonoscopy. ClinicalTrials.gov. http://www.clinicaltrials.gov/ct2/show /NCT00906997

  20. Northern-European Initiative on Colorrectal Cancer (NordICC). ClinicalTrials.10 gov. http://clinicaltrials.gov/ct2/show/NCT00883792

  21. Sano Y, Fujii T, Oda Y, Matsuda T, Kozu T, Kudo S, et al. Clinical trial note. A multicenter randomized controlled trial designed to evaluate follow-up surveillance strategies for colorrectal cancer: the japan polyp study. Digestive Endoscopy. 2004;16:376-8.

  22. Nozaki R. Endoscopic examination for colorrectal cancer screening. J Colon Exam. 2002;19:2939

  23. Fujii T, Sano Y, Iishi H. Colorrectal cancer screening in Japan: results of the multicenter retrospective cohort study. Gastroenterology. 2002;122:A481.

  24. Japan Polyp Study. (in Japanese). [citado 2 Ag. 2012] Disponible en: http://www.jps21.jp/index.html

  25. Peláez O. Registran prueba para pesquisa del cáncer de colon. Periódico Granma. 2012 Ag. 31; Secc. Nacionales (col.2 ). [citado 3 Sep. 2012] Disponible en: www.granma.cubaweb.cu/2012/08/31/nacional/artic11.html

  26. Davila RE, Rajan E, Baron TH. ASGE guideline: colorrectal cancer screening and surveillance. Gastrointest Endosc. 2006;63(4):54657.

  27. Grupo de trabajo de la guía de práctica clínica de prevención del cáncer colorrectal. Guía de práctica clínica. Barcelona: Asociación Española de Gastroenterología, Sociedad Española de Medicina de Familia y Comunitaria y Centro Cochrane Iberoamericano; 2009. [citado 13 Sep. 2012] Disponible en: http://www.guiasalud.es/GPC/GPC_494_colorrectal_(2009).pdf

  28. Sáenz Roque. Cáncer colorrectal. Una proposición de protocolos de diagnósticos y tratamiento para países de Latinoamérica. Reunión de Consenso. Santiago de Chile; 2004. [citado Jun. 7, 2008] Disponible en: http://www.aige.org/protocolos.php

  29. Seng Lee C, Leen R, O'Morain C, McNamara D. Screening for colorrectal cancer:what fits best?. Expert Rev Gastroenterol Hepatol. 2012;6(3):30112.

  30. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorrectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329(27):197781.

  31. Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorrectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7(7):7705.

  32. Brenner H, Chang-Claude J, Seiler CM,Rickert A, Hoffmeister M. Protection from colorrectal cancer after colonoscopy: a population-based, casecontrol study. Ann Intern Med. 2011;154(1):2230.

  33. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorrectal cancer. Ann Intern Med. 2009;150(1):18.

  34. Singh H, Penfold RB, DeCoster C, Kaita L, Proulx C, Taylor G, et al. Colonoscopy and its complications across a Canadian regional health authority. Gastrointest Endosc. 2009;69(3):66571.

  35. Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006;145(12):8806.

  36. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorrectal findings. N Engl J Med. 2000;343:169-74.

  37. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejpec G. One-time screening for colorrectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345:555-60.

  38. Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorrectal neoplasia after negative screening colonoscopy. N Engl J Med. 2008; 359:1218-24.

  39. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorrectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162-8.

  40. Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, Cardelli A, et al. Comparing Attendance and Detection Rate of Colonoscopy With Sigmoidoscopy and FIT for Colorrectal Cancer Screening. Gastroenterology. 2007;132:2304-12.

  41. Strul H, Kariv R, Leshno M, Halak A, Jakubowicz M, Santo M, et al. The prevalence rate and anatomic location of colorrectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40-80 years. Am J Gastroenterol. 2006;201:255-62.

  42. Schoenfeld P, Cash B, Flood A, Dobhan R, Eastone J, Coyle W, et al. Colonoscopic screening of average-risk women for colorrectal neoplasia. N Engl J Med. 2005;352:2061-68.

  43. Boursi B, Halak A, Umansky M, Galzan L, Guzner-Gur H, Arber N. Colonoscopic screening of an average-risk population for colorrectal neoplasia. Endoscopy. 2009;41:516-21.

  44. Zauber AG, Church TR, Mills G, Mandelson M, Allen JI, Jordan PA, et al. Detection of Proximal Adenomas by Colonoscopy Following Flexible Sigmoidoscopy Depends on the Colonoscopy Referral Algorithm: Analysis of the UK Flexible Sigmoidoscopy Study Algorithm Applied to the U.S. National Colonoscopy Study. Gastroenterology. 2011;140(5):S-16.

  45. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, Van Ballegooijen M, Hankey BF, et al. Colonoscopic Polypectomy and Long-Term Prevention of Colorrectal-Cancer Deaths. N Engl J Med. 2012;366:687-96.

  46. Manser CN, Bachmann LM, Brunner J, Hunold F, Bauerfeind P, Marbet UA. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc. 2012;76:110-7.

  47. Singh H, Nugent Z, Mahmud SM,Demers AA, Bernstein CN. Predictors of colorrectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol. 2010;105:663-73.

  48. Coe SG, Thomas C, Crook J, Ussui V, Diehl N, Wallace MB. Colorrectal surveillance interval assignment based on in vivo prediction of polyp histology: impact of endoscopic quality improvement program. Gastrointestinal Endoscopy. 2012; 76(1):188-25.

  49. Jover R, Herráiz M, Alarcón O, Brullet E, Bujanda L, Bustamante M, et al. Clinical practice Guidelines: quality of colonoscopy in colorrectal cancer screening. Endoscopy. 2012;44: 444-51.

  50. Froehlich F, Wietlisbach V, Gonvers J, Burnand B, Vader JP. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointestinal Endoscopy. 2005;61(3):378-84.

  51. Larsen M, Hills N, Terdiman J. The Impact of the Quality of Colon Preparation on Follow-Up Colonoscopy Recommendations. Am J Gastroenterol 2011;106:205862.

  52. Cohen L. One small step for colonoscopy, one giant leap for bowel preparation. Gastrointest Endosc. 2012;76(3):609-11.

  53. Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;362(19):1795-803.

  54. Adler A, Wegscheider K, Lieberman D, Aminalai A, Aschenbeck J, Drossel R, et al. Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12,134 examinations (Berlin colonoscopy project 3, CECOP-3). Gut. 22 Mar. 2012;. [Epub ahead of print] doi:10.1136/gutjnl-2011-300167. [citado 22 Sep. 2012] Disponible en: http://gut.bmj.com/content/early/2012/03/21/gutjnl-2011-300167

  55. Petersen BT. Quality assurance for endoscopists. Best Pract Res Clin Gastroenterol. 2011;25(3):349-60.

  56. Lee TJ, Rutter MD, Blanks RG, Moss SM, Goddard AF, Chilton A, et al. Colonoscopy quality measures: experience from the NHS bowel cancer screening programme. Gut. 2012;61:1050-7. doi:10.1136/gutjnl-2011-300651.

  57. Yong Yoo H, Sung Lee M, Min Ko B, Kyung Kim H, Su Ahn H, Hyo Han S, et al. Correlation of Narrow Band Imaging with Magnifying Colonoscopy and Histology in Colorrectal Tumors. Clin Endosc. 2011;44:44-50.

  58. Hewett DG, Huffman ME, Rex DK. Leaving distal colorrectal hyperplastic polyps in place can be achieved with high accuracy by using narrow-band imaging: an observational study. Gastrointest Endosc. 2012;76(2):374-80.




2020     |     www.medigraphic.com